Aesthetic Plastic Surgery

, Volume 13, Issue 1, pp 15–21

Subcutaneous mastectomy data: A final statistical analysis of 1500 patients

  • Vincent R. Pennisi
  • Angelo Capozzi


A statistical analysis of 1500 patients who underwent subcutaneous mastectomy is presented. Their data suggest that most patients who were treated by subcutaneous mastectomy had proliferative fibrocystic disease or macrocystic disease, among other high risk factors. The data also suggest that a thoroughly performed subcutaneous mastectomy is an effective means of providing prophylaxis in women who are at high risk for breast cancer. Conclusions were confirmed by many unsolicited comments of patients who underwent the procedure and were grateful to their doctors who performed it.

Key words

Subcutaneous mastectomy Statistical analysis Effectiveness of operative procedure 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bailar JC, Smith: Progress against cancer? New Engl J Med314:1226–1232, 1986PubMedGoogle Scholar
  2. 2.
    Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. New Engl J Med312:146, 1985PubMedGoogle Scholar
  3. 3.
    Eusebi V, Grassigli A, Grosso F: Lesioni focali scleroelastotiche mammarie simulanti il carcinoma infiltrante. Pathologica68:507–518, 1976PubMedGoogle Scholar
  4. 4.
    Fisher ER: What is early breast cancer? In Zander E, Baltzer J (eds): Early breast cancer. Berlin: Springer-Verlag, 1985Google Scholar
  5. 5.
    Gallager H, Martin JE: Early phases in the development of breast cancer. Cancer24:1170–1178, 1969PubMedGoogle Scholar
  6. 6.
    Goldman ID, Goldwyn RM: Some anatomic considerations of subcutaneous mastectomy. Plast Reconstr Surg50:211–215, 1972PubMedGoogle Scholar
  7. 7.
    Haagensen CD: Diseases of the breast. Philadelphia: WB Saunders, 1986Google Scholar
  8. 8.
    Hicken NF: Mastectomy: A clinical pathological study demonstrating why most mastectomies result in incomplete removal of the mammary gland. Arch Surg40:6–14, 1940Google Scholar
  9. 9.
    Linell F, Ljungsberg O, Andersson I: Breast carcinoma. Aspects of early stages, progression and related problems. Acta Pathol Microbiol Scand Suppl 272, 1980Google Scholar
  10. 10.
    Pennisi VR: Subcutaneous mastectomy and fibrocystic disease. Clin Plast Surg3:205, 1976PubMedGoogle Scholar
  11. 11.
    Pennisi VR: The prevention of breast cancer by subcutaneous mastectomy. Surg Clin N Am57:1023, 1977PubMedGoogle Scholar
  12. 12.
    Pennisi VR: Redefined indications for subcutaneous mastectomy in patients with benign breast diseases. Aesth Plast Surg10:101–104, 1986Google Scholar
  13. 13.
    Pennisi VR, Capozzi A: Treatment of chronic cystic mastitis by subcutaneous mastectomy. Plast Reconstr Surg52:520–524, 1973PubMedGoogle Scholar
  14. 14.
    Pennisi VR, Capozzi A: Subcutaneous mastectomy: an interim report on 1244 patients. Ann Plast Surg12:340, 1984PubMedGoogle Scholar
  15. 15.
    Pennisi VR, Capozzi A, Perez FM: Subcutaneous mastectomy data: A preliminary report. Plast Reconstr Surg59:53–56, 1977PubMedGoogle Scholar
  16. 16.
    Pennisi VR, Capozzi A, Perez FM: Subcutaneous mastectomy dat. BREAST5:18, 1979Google Scholar
  17. 17.
    Pennisi VR, Capozzi A, Walsh J, Christensen N: Obscure breast carcinoma encountered in subcutaneous mastectomies. Plast Reconstr Surg47:17–20, 1971PubMedGoogle Scholar
  18. 18.
    Pennisi VR, Lozado G, Capozzi A: Minimizing the complications of subcutaneous mastectomy. BREAST6:22–25, 1980Google Scholar
  19. 19.
    Tremblay G, Buell RH, Seemayer Th A: Elastosis in benign sclerosing ductal proliferation of the female breast. Am J Surg Pathol1:155, 1977PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc 1989

Authors and Affiliations

  • Vincent R. Pennisi
    • 1
  • Angelo Capozzi
    • 1
  1. 1.San FranciscoUSA

Personalised recommendations